van Waateringe, R. P., Slagter, S. N., van Beek, A. P., van der Klauw, M. M., van Vliet-Ostaptchouk, J. V., Graaff, R., . . . Wolffenbuttel, B. H. R. (2017). Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components. Diabetol Metab Syndr.
Citação norma Chicagovan Waateringe, Robert P., Sandra N. Slagter, Andre P. van Beek, Melanie M. van der Klauw, Jana V. van Vliet-Ostaptchouk, Reindert Graaff, Andrew D. Paterson, Helen L. Lutgers, and Bruce H. R. Wolffenbuttel. "Skin Autofluorescence, a Non-invasive Biomarker for Advanced Glycation End Products, Is Associated With the Metabolic Syndrome and Its Individual Components." Diabetol Metab Syndr 2017.
Citação norma MLAvan Waateringe, Robert P., et al. "Skin Autofluorescence, a Non-invasive Biomarker for Advanced Glycation End Products, Is Associated With the Metabolic Syndrome and Its Individual Components." Diabetol Metab Syndr 2017.